Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ellen G McMahon

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Current Pharmaceutical Design|April 8, 2003
Eplerenone, a new selective aldosterone blockerEllen G McMahon
Molecular and Cellular Endocrinology|May 12, 2004
The evolution of aldosterone antagonistsSusan M Garthwaite, Ellen G McMahon
Expert Opinion on Emerging Drugs|July 2, 2005
Emerging therapies for heart failureAmy E Rudolph, Ellen G McMahon
Molecular and Cellular Endocrinology|May 12, 2004
Aldosterone target organ protection by eplerenoneAmy E Rudolph, Ricardo Rocha, Ellen G McMahon
Mini Reviews in Medicinal Chemistry|August 17, 2005
Molecular mechanisms of mineralocorticoid receptor antagonism by eplerenoneXiao Hu, Suzhen Li, Ellen G McMahon, et al.
Kidney International|April 5, 2003
Aldosterone/salt induces renal inflammation and fibrosis in hypertensive ratsEileen R Blasi, Ricardo Rocha, Amy E Rudolph, et al.
Circulation Research|June 7, 2003
Transgenic model of aldosterone-driven cardiac hypertrophy and heart failureWenning Qin, Amy E Rudolph, Brian R Bond, et al.
American Journal of Physiology. Heart and Circulatory Physiology|October 18, 2002
Aldosterone induces a vascular inflammatory phenotype in the rat heartRicardo Rocha, Amy E Rudolph, Gregory E Frierdich, et al.
Circulation|December 4, 2002
Effects of long-term monotherapy with eplerenone, a novel aldosterone blocker, on progression of left ventricular dysfunction and remodeling in dogs with heart failureGeorge Suzuki, Hideaki Morita, Takayuki Mishima, et al.
American Journal of Physiology. Heart and Circulatory Physiology|October 18, 2002
Structural, functional, and molecular characterization of the SHHF model of heart failureJonathan R R Heyen, Eileen R Blasi, Kristen Nikula, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Current Pharmaceutical Design|April 8, 2003
Eplerenone, a new selective aldosterone blockerEllen G McMahon
Molecular and Cellular Endocrinology|May 12, 2004
The evolution of aldosterone antagonistsSusan M Garthwaite, Ellen G McMahon
Expert Opinion on Emerging Drugs|July 2, 2005
Emerging therapies for heart failureAmy E Rudolph, Ellen G McMahon
Molecular and Cellular Endocrinology|May 12, 2004
Aldosterone target organ protection by eplerenoneAmy E Rudolph, Ricardo Rocha, Ellen G McMahon
Mini Reviews in Medicinal Chemistry|August 17, 2005
Molecular mechanisms of mineralocorticoid receptor antagonism by eplerenoneXiao Hu, Suzhen Li, Ellen G McMahon, et al.
Kidney International|April 5, 2003
Aldosterone/salt induces renal inflammation and fibrosis in hypertensive ratsEileen R Blasi, Ricardo Rocha, Amy E Rudolph, et al.
Circulation Research|June 7, 2003
Transgenic model of aldosterone-driven cardiac hypertrophy and heart failureWenning Qin, Amy E Rudolph, Brian R Bond, et al.
American Journal of Physiology. Heart and Circulatory Physiology|October 18, 2002
Aldosterone induces a vascular inflammatory phenotype in the rat heartRicardo Rocha, Amy E Rudolph, Gregory E Frierdich, et al.
Circulation|December 4, 2002
Effects of long-term monotherapy with eplerenone, a novel aldosterone blocker, on progression of left ventricular dysfunction and remodeling in dogs with heart failureGeorge Suzuki, Hideaki Morita, Takayuki Mishima, et al.
American Journal of Physiology. Heart and Circulatory Physiology|October 18, 2002
Structural, functional, and molecular characterization of the SHHF model of heart failureJonathan R R Heyen, Eileen R Blasi, Kristen Nikula, et al.
Pageof 1